Public disclosures

VANI insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Mendelsohn Aaron

Director · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Equity grant or award
Filing details

SEC transaction code A

Original filed 2026-11-19

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 997327 · The reporting person purchased 99,010 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of November 15, 2026 at a price of $1.01 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026). The gross proceeds from this private sale transaction were $100,000.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. · On November 19, 2026, the reporting person filed a Form 4 which inadvertently included an incorrect transaction code due to an administrative error. This amendment is being filed to reflect the correct transaction code "A" instead of transaction code "D." · The reporting person owns 1,165,497 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 846,397 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares of the 846,397 shares of common stock owned by MFE, LLC, which 169,279 shares are beneficially owned by other members of the limited liability company.

2026-11-182026-11-20

99,010 shares/units

SEC 4/A

Amendment

Follow
Williams Gregg

Director · 10% owner · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 37111299 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. · The reporting person owns 41,910,499 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,985,547 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

2026-11-192026-11-20

≈ $93,365.18

85,265 shares/units

SEC 4Follow
Williams Gregg

Director · 10% owner · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 37026034 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. · The reporting person owns 41,910,499 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,985,547 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

2026-11-182026-11-20

≈ $34,960.13

33,169 shares/units

SEC 4Follow
Mendelsohn Aaron

Director · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Equity grant or award
Filing details

SEC transaction code A

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 997327 · The reporting person purchased 99,010 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of November 15, 2026 at a price of $1.01 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026). The gross proceeds from this private sale transaction were $100,000.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. · The reporting person owns 1,165,497 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 846,397 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares of the 846,397 shares of common stock owned by MFE, LLC, which 169,279 shares are beneficially owned by other members of the limited liability company.

2026-11-182026-11-19

99,010 shares/units

SEC 4Follow
Williams Gregg

Director · 10% owner · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 36992865 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.01 to $1.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. · The reporting person owns 41,792,065 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,867,113 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

2026-11-172026-11-18

≈ $31,455.38

29,929 shares/units

SEC 4Follow
Williams Gregg

Director · 10% owner · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 36962936 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The reporting person owns 41,792,065 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,867,113 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

2026-11-162026-11-18

≈ $2,121.00

2,100 shares/units

SEC 4Follow
Williams Gregg

Director · 10% owner · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 36960836 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.921 to $1.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. · The reporting person owns 41,760,036 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,835,084 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

2026-11-132026-11-16

≈ $47,763.30

48,100 shares/units

SEC 4Follow
Dwyer Donald

Chief Business Officer · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 75000 · SEC code covers open-market or private transactions · Individual purchased shares on the open market. · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2026-11-122026-11-13

≈ $15,495.00

15,000 shares/units

SEC 4Follow
Dwyer Donald

Chief Business Officer · Vivani Medical, Inc.

VANI

Vivani Medical, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 60000 · SEC code covers open-market or private transactions · Individual purchased shares on the open market.

2026-11-122026-11-13

≈ $4,150.00

5,000 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement